NO166180C - Analogifremgangsmaate for fremstilling av ace-inhiberende forbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av ace-inhiberende forbindelser.

Info

Publication number
NO166180C
NO166180C NO863457A NO863457A NO166180C NO 166180 C NO166180 C NO 166180C NO 863457 A NO863457 A NO 863457A NO 863457 A NO863457 A NO 863457A NO 166180 C NO166180 C NO 166180C
Authority
NO
Norway
Prior art keywords
alkyl
phenyl
hydrogen
group
atoms
Prior art date
Application number
NO863457A
Other languages
English (en)
Norwegian (no)
Other versions
NO166180B (no
NO863457L (no
NO863457D0 (no
Inventor
Roger Charles Brown
David Hulme Robinson
John Dixon
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858521697A external-priority patent/GB8521697D0/en
Priority claimed from GB858524932A external-priority patent/GB8524932D0/en
Priority claimed from GB858530143A external-priority patent/GB8530143D0/en
Priority claimed from GB868609793A external-priority patent/GB8609793D0/en
Priority claimed from GB868612060A external-priority patent/GB8612060D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of NO863457D0 publication Critical patent/NO863457D0/no
Priority claimed from SU874202059A external-priority patent/RU1804458C/ru
Publication of NO863457L publication Critical patent/NO863457L/no
Priority to NO873618A priority Critical patent/NO166181C/no
Publication of NO166180B publication Critical patent/NO166180B/no
Publication of NO166180C publication Critical patent/NO166180C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO863457A 1985-08-31 1986-08-28 Analogifremgangsmaate for fremstilling av ace-inhiberende forbindelser. NO166180C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO873618A NO166181C (no) 1985-08-31 1987-08-27 Mellomprodukter.

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB858521697A GB8521697D0 (en) 1985-08-31 1985-08-31 Nitrogen & sulphur heterocycles
GB858524932A GB8524932D0 (en) 1985-10-09 1985-10-09 Nitrogen & sulphur heterocycles
GB858530143A GB8530143D0 (en) 1985-12-06 1985-12-06 Nitrogen
GB868609793A GB8609793D0 (en) 1986-04-22 1986-04-22 Nitrogen containing heterocycles
GB868612060A GB8612060D0 (en) 1986-05-17 1986-05-17 Nitrogen containing heterocycles
SU874202059A RU1804458C (ru) 1985-08-31 1987-02-09 Способ получени производных 1,3,4-тиадиазол-2-карбоновых кислот или их фармацевтически приемлемых солей, сложных эфиров или амидов

Publications (4)

Publication Number Publication Date
NO863457D0 NO863457D0 (no) 1986-08-28
NO863457L NO863457L (no) 1987-03-02
NO166180B NO166180B (no) 1991-03-04
NO166180C true NO166180C (no) 1991-06-19

Family

ID=27546912

Family Applications (1)

Application Number Title Priority Date Filing Date
NO863457A NO166180C (no) 1985-08-31 1986-08-28 Analogifremgangsmaate for fremstilling av ace-inhiberende forbindelser.

Country Status (19)

Country Link
US (1) US4927822A (fr)
EP (1) EP0217519B1 (fr)
JP (1) JPH0788365B2 (fr)
KR (1) KR940009528B1 (fr)
AT (1) ATE72431T1 (fr)
AU (1) AU591165B2 (fr)
BE (1) BE905351A (fr)
CA (1) CA1305286C (fr)
CH (1) CH671397A5 (fr)
DK (1) DK406386A (fr)
FI (1) FI87205C (fr)
FR (1) FR2586679B1 (fr)
GR (1) GR862234B (fr)
IE (1) IE59432B1 (fr)
IL (1) IL79841A (fr)
LU (1) LU86569A1 (fr)
NO (1) NO166180C (fr)
NZ (1) NZ217398A (fr)
PT (1) PT83277B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87616B (pt) * 1987-06-24 1992-09-30 Smithkline Beecham Corp Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas
GB8825541D0 (en) * 1988-11-01 1988-12-07 Fisons Plc Formulation
WO1994020460A1 (fr) * 1993-03-11 1994-09-15 Smithkline Beecham Corporation Composes chimiques
PT1847534E (pt) * 2001-12-11 2011-08-01 Kyowa Hakko Kirin Co Ltd Derivado de tiadiozolina para o tratamento do cancro
US7851635B2 (en) 2003-04-18 2010-12-14 Kyowa Hakko Kirin Co., Ltd. Mitotic kinesin inhibitor
CN1802361A (zh) * 2003-06-10 2006-07-12 协和发酵工业株式会社 噻二唑啉衍生物
JPWO2004111023A1 (ja) * 2003-06-10 2006-07-27 協和醗酵工業株式会社 チアジアゾリン−1−オキシド誘導体
WO2005035512A1 (fr) * 2003-10-10 2005-04-21 Kyowa Hakko Kogyo Co., Ltd. Derives de thiadiazoline
US7449486B2 (en) * 2004-10-19 2008-11-11 Array Biopharma Inc. Mitotic kinesin inhibitors and methods of use thereof
TW200720265A (en) * 2005-03-22 2007-06-01 Kyowa Hakko Kogyo Kk Agent for treatment of hematopoietic tumor
TW200714593A (en) * 2005-03-22 2007-04-16 Kyowa Hakko Kogyo Kk Agent for treatment of solid tumor
UA95907C2 (en) 2005-05-02 2011-09-26 Эррей Биофарма Инк. Mitotic kinesin inhibitors and methods of use thereof
WO2006137490A1 (fr) 2005-06-24 2006-12-28 Kyowa Hakko Kogyo Co., Ltd. Agent thérapeutique contre la resténose
DE102006002065B4 (de) * 2006-01-16 2007-11-29 Infineon Technologies Austria Ag Kompensationsbauelement mit reduziertem und einstellbarem Einschaltwiderstand
KR20090045354A (ko) 2006-08-21 2009-05-07 신타 파마슈티칼스 코프. 증식성 장애를 치료하기 위한 화합물
JP2010505870A (ja) * 2006-10-03 2010-02-25 アレイ バイオファーマ、インコーポレイテッド 有糸分裂キネシン阻害剤としてのオキサジアゾール誘導体およびチアジアゾール誘導体、ならびにそれらの使用方法
WO2009073148A2 (fr) * 2007-11-28 2009-06-11 Synta Pharmaceuticals Corp. Polymorphes de n-malonyl-bis(n'-méthyl-n'-thiobenzoylhydrazide)
TW200940050A (en) * 2007-11-28 2009-10-01 Synta Pharmaceuticals Corp Polymorphs of N-malonyl-bis(N'-methyl-N'-thiobenzoylhydrazide)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4091024A (en) 1976-12-03 1978-05-23 E. R. Squibb & Sons, Inc. Pyrrolidine and piperidine-2-carboxylic acid derivatives
US4198517A (en) * 1976-12-03 1980-04-15 E. R. Squibb & Sons, Inc. Histidine derivatives
IL58849A (en) 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4254267A (en) * 1979-10-25 1981-03-03 E. R. Squibb & Sons, Inc. Mercaptoacyldihydropyrazole carboxylic acid derivatives
US4312990A (en) * 1980-09-11 1982-01-26 E. R. Squibb & Sons, Inc. 1-Mercaptoacyl-3-[(aminosulfonyl) phenyl]-4,5-dihydro-1H-pyrazole-5-carboxylic acid
EP0048159A3 (fr) * 1980-09-17 1982-05-12 University Of Miami Peptides carboxyalcoyliques, thioéthers et éthers de peptides comme agents antihypertensifs

Also Published As

Publication number Publication date
NZ217398A (en) 1989-04-26
FI87205B (fi) 1992-08-31
IE862322L (en) 1987-02-28
NO166180B (no) 1991-03-04
KR870002107A (ko) 1987-03-30
US4927822A (en) 1990-05-22
IL79841A0 (en) 1986-11-30
PT83277A (en) 1986-09-01
JPS6253976A (ja) 1987-03-09
AU6179886A (en) 1987-03-05
PT83277B (pt) 1989-03-30
NO863457L (no) 1987-03-02
FI863488A0 (fi) 1986-08-28
DK406386A (da) 1987-03-01
NO863457D0 (no) 1986-08-28
FR2586679A1 (fr) 1987-03-06
FI87205C (fi) 1992-12-10
FR2586679B1 (fr) 1988-12-30
IL79841A (en) 1992-02-16
AU591165B2 (en) 1989-11-30
EP0217519A1 (fr) 1987-04-08
EP0217519B1 (fr) 1992-02-05
ATE72431T1 (de) 1992-02-15
CH671397A5 (fr) 1989-08-31
JPH0788365B2 (ja) 1995-09-27
KR940009528B1 (ko) 1994-10-14
LU86569A1 (fr) 1986-12-02
IE59432B1 (en) 1994-02-23
CA1305286C (fr) 1992-07-14
DK406386D0 (da) 1986-08-26
GR862234B (en) 1986-12-31
BE905351A (fr) 1987-03-02
FI863488A (fi) 1987-03-01

Similar Documents

Publication Publication Date Title
NO166180C (no) Analogifremgangsmaate for fremstilling av ace-inhiberende forbindelser.
ES8601880A1 (es) Un procedimiento para la preparacion de derivados del indol
DE3861926D1 (de) Polyzyklische aromatische verbindungen, verfahren zu deren herstellung, deren verwendung in menschlicher und tierischer medizin und in der kosmetik.
AU639154B2 (en) New imidazole compounds, a process for the preparation thereof, and pharmaceutical compositions containing them
DE3867884D1 (de) Aromatische derivate der butyrsaeure, verfahren zu ihrer herstellung und ihre verwendung in kosmetischen und pharmazeutischen zubereitungen.
YU140491A (sh) 6-supstituisani-tetrahidrobenz(c,d) indoli
ES8401456A1 (es) Procedimiento para la preparacion de 2-aminometilfenoles.
ES435361A1 (es) Un metodo para la preparacion de nuevos esteres alcohilicosde aminoacidos.
ZA899321B (en) Indole derivatives,process for preparing them and pharmaceutical compositions containing them
SE8302452D0 (sv) Method for treatment of senile dementia
MY101878A (en) 1,3,4-thiadiazole
DE3862660D1 (de) 2,3-dihydro-2-oxo-3-benzofuranyl-essigsaeurederivate und diese enthaltende arzneimittel.
NZ238431A (en) ((1-arylpyrrolidin-2-yl)methyl)piperazine derivatives; pharmaceutical compositions and preparatory processes
DE3860117D1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-on-acetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DK513281A (da) Fremgangsaade til fremstilling af 3-thiovinylcephalosproner
NO167201C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive semikarbazid-derivater.